City of New York Early-Stage Life Sciences Funding Initiative Overview
- Fund Type
-
Venture
- Fund Status
-
Closed
- Fund Manager
- ARCH Venture Par...
- (You're viewing 1 of 3)
- Size
-
- Vintage
-
2014
- Dry Powder
-
City of New York Early-Stage Life Sciences Funding Initiative General Information
Description
City of New York Early-Stage Life Sciences Funding Initiative is a 2014 vintage early-stage venture capital fund co-managed by New York City Economic Development, Flagship Pioneering, and ARCH Venture Partners. The fund is located in Chicago, Illinois, and invests in New York Metro region. The fund targets healthcare technology systems, healthcare devices, supplies, pharmaceuticals, and biotechnology sectors. The fund prefers to invest in 15-20 companies.
Contact Information
Fund Manager's Location
- 8755 West Higgins Road
- Suite 1025
- Chicago, IL 60631
- United States
City of New York Early-Stage Life Sciences Funding Initiative Investments (3)
City of New York Early-Stage Life Sciences Funding Initiative has made a total of 3 investments. Its most recent deal was a with HiberCell for . The deal was made on 07-Feb-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| HiberCell | 07-Feb-2019 | Drug Discovery | Pre-Clinical Trials | |||
| DogSpot | 11-Dec-2018 | Other Services (B2C Non-Financial) | Generating Revenue | |||
| Quentis Therapeutics | 03-Dec-2018 | Grant | Drug Discovery | Product Development |
City of New York Early-Stage Life Sciences Funding Initiative Investment Strategy
Investments by Industry
Investments by Deal Type
City of New York Early-Stage Life Sciences Funding Initiative Limited Partners (1)
Versant Ventures is the sole limited partner of City of New York Early-Stage Life Sciences Funding Initiative. Its latest Original was on 05-Jan-2016.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Versant Ventures | Former | 05-Jan-2016 | Original |
City of New York Early-Stage Life Sciences Funding Initiative Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
City of New York Early-Stage Life Sciences Funding Initiative Benchmark (375)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Innova Fund III | |||||
| Moonscape Ventures | |||||
| Amplify Partners | |||||
| Marker II | |||||
| Maveron V Entrepreneurs' Fund | 31-Mar-2020 | ||||
| Fisher Lynch Venture Fund III | |||||
| MEP Associates V | 31-Mar-2020 | ||||
| Romulus Capital II | |||||
| City of New York Early-Stage Life Sciences Funding Initiative | |||||
| IncWell II |
City of New York Early-Stage Life Sciences Funding Initiative FAQs
-
What is City of New York Early-Stage Life Sciences Funding Initiative?
City of New York Early-Stage Life Sciences Funding Initiative is a 2014 vintage early-stage venture capital fund co-managed by New York City Economic Development, Flagship Pioneering, and ARCH Venture Partners.
-
Who manages City of New York Early-Stage Life Sciences Funding Initiative?
City of New York Early-Stage Life Sciences Funding Initiative is managed by ARCH Venture Partners, Flagship Pioneering, and New York City Economic Development.
-
Where is City of New York Early-Stage Life Sciences Funding Initiative domiciled?
City of New York Early-Stage Life Sciences Funding Initiative is domiciled in United States.
-
What is City of New York Early-Stage Life Sciences Funding Initiative's size?
City of New York Early-Stage Life Sciences Funding Initiative has a size of .
-
What type of fund is City of New York Early-Stage Life Sciences Funding Initiative?
The fund type of City of New York Early-Stage Life Sciences Funding Initiative is Venture.
-
What is the status of City of New York Early-Stage Life Sciences Funding Initiative?
City of New York Early-Stage Life Sciences Funding Initiative is closed.
-
What has City of New York Early-Stage Life Sciences Funding Initiative invested in?
City of New York Early-Stage Life Sciences Funding Initiative has made numerous investments in companies like HiberCell, DogSpot, and Quentis Therapeutics within the Drug Discovery and Services (B2C Non-Financial) industries.
-
What has City of New York Early-Stage Life Sciences Funding Initiative invested in recently?
City of New York Early-Stage Life Sciences Funding Initiative's latest investment was on 07-Feb-2019 in HiberCell, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
